checkAd

     101  0 Kommentare Bristol Myers Squibb to Present at J.P. Morgan’s 40th Annual Healthcare Conference

    Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 40th Annual Virtual Healthcare Conference on Monday, January 10, 2022. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. ET.

    The event will be webcast simultaneously at http://investor.bms.com with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the event.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Bristol-Myers Squibb!
    Long
    45,56€
    Basispreis
    0,73
    Ask
    × 5,73
    Hebel
    Short
    61,32€
    Basispreis
    0,76
    Ask
    × 5,65
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    About Bristol Myers Squibb

    Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

    corporatefinancial-news



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Bristol Myers Squibb to Present at J.P. Morgan’s 40th Annual Healthcare Conference Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 40th Annual Virtual Healthcare Conference on Monday, January 10, 2022. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal …

    Artikel zu den Werten

    Schreibe Deinen Kommentar

    Disclaimer